Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES)
Public ClinicalTrials.gov record NCT05026710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES) A Pragmatic Randomized Multi-center Comparative Effectiveness Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This multi-center trial is being completed to compare patient outcomes related to the Imajin silicone stent in comparison to non-silicone polyurethane stents after ureteroscopy. Eligible participants will be enrolled and randomly assigned to receive the Imajin silicone stent or a non-silicone stent. In addition, the participants will complete questionnaires and have follow-up information collected (approximately 60 days after surgery). The trial hypothesizes that a ureteral stent made of silicone, will have superior outcomes when compared to non-silicone stents.
Study identification
- NCT ID
- NCT05026710
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 224 participants
Conditions and interventions
Conditions
Interventions
- Silicone (Coloplast Imajin Hydro) ureteral stent Device
- Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer) Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2, 2021 (Actual)
- Primary completion
- Jul 1, 2024 (Actual)
- Completion
- Aug 21, 2024 (Actual)
- Last update posted
- Oct 28, 2025
2021 – 2024
United States locations
- U.S. sites
- 10
- U.S. states
- 1
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Michigan Medicine | Ann Arbor | Michigan | 48109 | — |
| Michigan Medicine | Brighton | Michigan | 48116 | — |
| Chelsea Hospital (Saint Joseph Mercy) | Chelsea | Michigan | 48118 | — |
| Henry Ford Macomb Hospital | Clinton Township | Michigan | 48038 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| Ascension Hospital (Comprehensive Urology) | Novi | Michigan | 48374 | — |
| William Beaumont Hospital (Michigan Institute of Urology) | Royal Oak | Michigan | 48073 | — |
| William Beaumont Hospital (Michigan Institute of Urology) | Troy | Michigan | 48085 | — |
| Henry Ford West Bloomfield Hospital | West Bloomfield | Michigan | 48322 | — |
| Integrated Healthcare Association (IHA) (Saint Joseph Mercy Hospital) | Ypsilanti | Michigan | 48197 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05026710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 28, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05026710 live on ClinicalTrials.gov.